R
Ron Pisters
Researcher at Maastricht University Medical Centre
Publications - 83
Citations - 12119
Ron Pisters is an academic researcher from Maastricht University Medical Centre. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 24, co-authored 67 publications receiving 10515 citations. Previous affiliations of Ron Pisters include Maastricht University & University of Birmingham.
Papers
More filters
Journal ArticleDOI
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
Ron Pisters,Ron Pisters,Robby Nieuwlaat,Martin H. Prins,Jean-Yves Le Heuzey,Aldo P. Maggioni,A. John Camm,Harry J.G.M. Crijns,Harry J.G.M. Crijns +8 more
TL;DR: In this article, the authors describe present-day cardioversion of atrial fibrillation and identify characteristics associated with immediate and long-term outcome, including Paroxysmal Atrial Fibrillation (PAF), absence of chronic obstructive pulmonary disease (COPD) (P < 0.004), and heart failure (P = 0.007) were predictive.
Journal ArticleDOI
Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey
Cees B. de Vos,Robby Nieuwlaat,Harry J.G.M. Crijns,A. John Camm,Jean-Yves LeHeuzey,Charles J. H. J. Kirchhof,Alessandro Capucci,Günter Breithardt,Panos E. Vardas,Ron Pisters,Robert G. Tieleman +10 more
TL;DR: This study is the first to address the issue of autonomic trigger patterns and AF in a large population of patients with paroxysmal atrial fibrillation associated with autonomic triggers and Autonomic trigger patterns were seen frequently in paroxYSmal AF patients.
Journal ArticleDOI
Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls.
Bob Weijs,Ron Pisters,Rutger J. Haest,Johannes A. Kragten,Ivo A. Joosen,Mathijs O. Versteylen,Carl Timmermans,Laurent Pison,Yuri Blaauw,Leonard Hofstra,Robby Nieuwlaat,Joachim E. Wildberger,Harry J.G.M. Crijns +12 more
TL;DR: Half of patients originally diagnosed with idiopathic paroxysmal AF show concealed underlying coronary artery disease, and the detection and treatment of CAD at an early stage could improve the prognosis of these patients.
Journal ArticleDOI
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies
Marcello Di Nisio,Maria Cristina Vedovati,Antoni Riera-Mestre,Martin H. Prins,Katharina Mueller,Alexander T. Cohen,Philip S. Wells,Jan Beyer-Westendorf,Paolo Prandoni,Henri Bounameaux,Dagmar Kubitza,Jonas Schneider,Ron Pisters,Jan Fedacko,Ricardo Fontes-Carvalho,Anthonie W. A. Lensing +15 more
TL;DR: The fixed-dose rivaroxaban regimen is not associated with an increased risk of major bleeding or recurrent VTE in patients with either a low or high bodyweight.
Journal ArticleDOI
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey.
TL;DR: The utilisation of apixaban and dabigatran for thromboprophylaxis could provide a profound annual mathematical net clinical benefit on stroke and major bleeds, in European AF patients.